drs. J.M. van Rooijen

E-mail:
j.m.van.rooijen umcg.nl
Research
Publications
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
PLCRC-MEDOCC group, Schraa, S. J., van Rooijen, K. L., van der Kruijssen, D. E. W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M. H., van Grevenstein, W. M. U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J. W., van den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J. A., Vink, G. R. & Koopman, M., 20-Aug-2020, In : BMC Cancer. 20, 1, 10 p., 790.Research output: Contribution to journal › Article › Academic › peer-review
High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Qiu, S-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schroder, C. P., 18-Mar-2020, In : Breast cancer research. 22, 1, 10 p., 30.Research output: Contribution to journal › Article › Academic › peer-review
Optimizing systemic therapy in metastatic breast cancer: implementation in daily practice and exploration of new drug targets
van Rooijen, J., 2020, [Groningen]: Rijksuniversiteit Groningen. 144 p.Research output: Thesis › Thesis fully internal (DIV)
Immunotherapeutic options on the horizon in breast cancer treatment
van Rooijen, J. M., Stutvoet, T. S., Schröder, C. P. & de Vries, E. G. E., Dec-2015, In : Pharmacology & Therapeutics. 156, p. 90-101 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
ID: 95078182